Genetic aspects in sarcoidosis

European Respiratory Journal

Volumn 16, Issue 4, 2000, Pages 768-780

  Luisetti, M ^a   Beretta, A ^a   Casali, L ^a  

^a IRCCS   (Italy)

Author keywords

Angiotensin converting enzyme; Candidate genes; Deoxyribonucleic acid; Epidemiology; Linkage analysis; Major histocompatibility complex

Indexed keywords

HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ENVIRONMENTAL FACTOR; ETHNIC GROUP; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HLA SYSTEM; HUMAN; INCIDENCE; MAJOR HISTOCOMPATIBILITY COMPLEX; PATHOGENESIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SARCOIDOSIS;

ENVIRONMENTAL EXPOSURE; HUMANS; RISK FACTORS; SARCOIDOSIS;

EID: 0033768833     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.16d31.x     Document Type: Review

References (117)

1. Sarcoidosis
2. Immunologic events in the development of interstitial lung disease: The paradigm of sarcoidosis
3. Sarcoidosis: Immunopathogenetic concepts and their clinical application
4. ATS/ERS/WASOG statement on sarcoidosis
5. NHLBI Workshop Summary. Advances in molecular genetics, transgenic models, and gene therapy for the study of pulmonary diseases
6. Genetics of sarcoidosis
7. Genetic risk factors for chronic obstructive pulmonary disease
8. Immunogenetic basis of environmental lung disease: Lessons from the berylliosis model
9. Design of A Case Control Etiologic Study of Sarcoidosis (ACCESS)
10. Racial differences in cardiac sarcoidosis incidence observed at autopsy
11. Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture
12. Epidemiology of sarcoidosis
13. The epidemiology of sarcoidosis in Rochester. Minnesota: A population based study of incidence and survival
14. Incidence of clinically identified sarcoidosis in a Northwest United States population
15. The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study
16. Epidemiology of sarcoidosis in the US Navy
17. Racial differences in sarcoidosis incidence: A 5 year study in a health maintenance organization
18. Patterns of sarcoidosis in three population groups in New York City
19. The mode of presentation of sarcoidosis in Finland and Hokkaoido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients
20. The sarcoidosis map': A joint survey of clinical and immunogenetic findings in two European Countries
21. Sarcoidosis mortality in the United States, 1979-1991: An analysis of multiple-cause mortality data
22. Epidemiology, demographics, and genetics of sarcoidosis
23. Temporal clustering of familial sarcoidosis in nonconsanguineous relatives
24. The incidence, prevalence, and severity of sarcoidosis in New York City Firefighters
25. Seasonal clustering of sarcoidosis presenting with erythema nodosum
26. Epidemiological study on sarcoidosis in Japan. Recent trends in incidence and prevalence rates and changes in epidemiological features
27. Sarcoidosis and transplantation
28. Epidemiology of sarcoidosis in the Isle of Man - 1: A case controlled study
29. Epidemiology of sarcoidosis in the Isle of Man 2: Evidence for space-time clustering
30. Mycobacteria and sarcoidosis: An overview and summary of recent molecular biological data
31. Prevalence of sarcoidosis in the Irish Republic
32. Epidemiology
33. Familial associations in sarcoidosis
34. High prevalence of familial sarcoidosis in an Irish population
35. Familial sarcoidosis in Finland and Hokkaido, Japan- a comparative study
36. Familial sarcoidosis: Analysis of 91 families
37. Familial sarcoidosis with multiple occurrences in eleven families: A possible mechanism of inheritance
38. Possible genetic influences in familial sarcoidosis
39. Heterogeneity of familial risk in sarcoidosis
40. Genetics of sarcoidosis
41. Molecular approaches for screening of genetic diseases
42. Genetics of complex diseases. Approaches, problems, and solutions
43. Mapping disease genes: Family-based associations studies
44. HLA antigens of patients with sarcoidosis
45. HLA antigens in sarcoidosis
46. HLA-B8 in sarcoidosis
47. HLA antigens associated with sarcoidosis
48. HLA association studies in black sarcoidosis patients
49. HLA in familial sarcoidosis
50. Genetic aspects of sarcoidosis. Class II histocompatibility antigens and a family study
51. HLA class I, II, III polymorphisms in Italian patients with sarcoidosis
52. Role of HLA-DR antigens in Japanese patients with sarcoidosis
53. HLA and sarcoidosis in the Japanese
54. HLA class II (DR, DQ, DP) in patients with sarcoidosis: Evidence of and increase frequency of DRw6
55. HLA class II associated genetic susceptibility in multiple sclerosis: A critical evaluation
56. Analysis of restriction fragment length polymorphism for the HLA-DR gene in Japanese patients with sarcoidosis
57. Molecular genetic studies of HLA class II alleles in sarcoidosis
58. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis
59. HLA-DPB1 glutamate 69: A genetic marker of beryllium disease
60. Role of the HLA-DP gene in susceptibility to lung granulomas
61. Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis
62. HLA-DPB polymorphisms: Glu69 association with sarcoidosis
63. HLA-DQB1 and HLA-DPB1 genotypes in familial sarcoidosis
64. Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis
65. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters
66. A proteasome related gene between the two ABC-transporter loci in the class II region of the human MHC
67. LMP7 polymorphism in Japanese with sarcoidosis and Behcet's disease
68. Genetic polymorphisms of the major histocompatibility complex-encoded antigenprocessing genes TAP and LMP in sarcoidosis
69. Analysis of allelic variation of the TAP2 gene in sarcoidosis
70. Genetic polymorphism in intron 6 of the LMP7 gene in Japanese and its association with sarcoidosis
71. Sarcoidosis and major histocompatibility complex genes with special emphasis on BF F subtypes
72. Tumor necrosis factor alpha promoter gene polymorphism in sarcoidosis
73. Role of the tumor necrosis factor α - 308 polymorphism in pulmonary sarcoidosis
74. Genetic polymorphisms of the TNFB and HSP70 genes located in the human major histocompatibility complex in sarcoidosis
75. Association of HLA B8 with spontaneous resolution in sarcoidosis
76. HLA-B8/DR3 in sarcoidosis. Correlation to acute onset disease with arthritis
77. Association of HLA-DR with sarcoidosis. Correlation with clinical course
78. Clinical features of sarcoidosis in relation to HLA distribution and HLA-DRB3 genotyping by PCR-RFLP
79. Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis
80. HLA associations in sarcoidosis: A study of two ethnic groups
81. T-cell receptor genes in sarcoidosis
82. The influence of T cell receptor and cytokine genes on sarcoidosis susceptibility in African Americans
83. T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients
84. Restricted usage of T cell receptor Vα/Jα gene segments with different nucleotide but identical amino acid sequences in HLA-DR3+ sarcoidosis patients
85. T-cell receptor V gene expression in HLA-typed Japanese patients with pulmonary sarcoidosis
86. Lung T-helper cells expressing T-cell receptor AV2S3 associate with clinical features of sarcoidosis
87. The riddle of sarcoidosis: Have novel techniques brought any new insights as to the causative agent?
88. Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis
89. Sarcoidosis, HLA and immunoglobulin markers in Baltimore blacks
90. HLA- GM/KM interaction in sarcoidosis. Suggestions for a complex genetic structure
91. Angiotensin-converting enzyme
92. Familial elevation of serum angiotensin converting enzyme
93. Familial elevation of serum angiotensin converting enzyme activity
94. An insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene accounting for half the variance of serum enzyme levels
95. Polymorphism of angiotensin-converting enzyme gene in sarcoidosis
96. Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis
97. The angiotensin converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients
98. Polymorphism in the angiotensin-converting enzyme (ACE) gene and sarcoidosis
99. Deletion polymorphism in the angiotensin I converting enzyme (ACE) as a genetic risk factor for sarcoidosis
100. Bronchial responsiveness and angiotensin-converting enzyme gene polymorphism in sarcoidosis patients
101. Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis
102. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis
103. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation
104. The role of the C-C chemokine receptor 2 gene polymorphism V641 (CCR2-641) in sarcoidosis in a Japanese population
105. Analysis of a large kindred with Blau syndrome for HLA, autoimmunity, and sarcoidosis
106. A comparison of Blau's syndrome and sarcoidosis
107. Sarcoidosis and Crohn's disease in siblings
108. Familial occurrence of sarcoidosis and Crohn's disease
109. Familial idiopathic granulomatosis: Sarcoidosis and Crohn's disease in two Indian families
110. The Blau syndrome gene is not a major risk factor for sarcoidosis
111. Results from a whole genome search for predisposing genes in sarcoidosis
112. The locomotor system
113. Vitamin D receptor gene polymorphism in patients with sarcoidosis
114. Complete mutational screening of the CFTR gene in 120 patients with pulmonary disease
115. Increased frequency of CFTR gene mutations in sarcoidosis: A case-control association study
116. Defining organ involvement in sarcoidosis: The ACCESS proposed instrument